Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Acq. announced
Director departure
Inv. presentation
Quarterly results
Consulting agrmnt
Appointed COO
Appointed director
CC transcript

BIOGEN INC. (BIIB) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
09/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/28/2023 8-K/A Quarterly results
09/28/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/26/2023 8-K Quarterly results
08/07/2023 SC 13D BIOGEN INC. reports a 23.4% stake in REATA PHARMACEUTICALS, INC.
08/07/2023 3 BIOGEN INC. (See footnotes) has filed a Form 3 on REATA PHARMACEUTICALS INC
07/31/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/31/2023 8-K Quarterly results
07/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/28/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Biogen to Acquire Reata Pharmaceuticals",
"Investor Webcast Presentation, prepared by the Company"
07/25/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/25/2023 8-K Quarterly results
07/05/2023 4 Izzar Rachid (Head of Global Product Strat.) has filed a Form 4 on BIOGEN INC.
Txns: Paid exercise price by delivering 244 shares @ $284.85, valued at $69.5k
Exercised 504 restricted stock units @ $0
07/05/2023 4 Kramer Robin (Chief Accounting Officer) has filed a Form 4 on BIOGEN INC.
Txns: Paid exercise price by delivering 122 shares @ $284.85, valued at $34.8k
Exercised 252 restricted stock units @ $0
07/05/2023 4 Singhal Priya (Head of Development) has filed a Form 4 on BIOGEN INC.
Txns: Paid exercise price by delivering 153 shares @ $284.85, valued at $43.6k
Sold 81 shares @ $282.87, valued at $22.9k
Exercised 315 restricted stock units @ $0
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/29/2023 8-K Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits  Interactive Data
06/28/2023 4 SHERWIN STEPHEN A (Director) has filed a Form 4 on BIOGEN INC.
Txns: Granted 960 shares @ $0
06/28/2023 4 Rowinsky Eric K (Director) has filed a Form 4 on BIOGEN INC.
Txns: Granted 960 shares @ $0
06/28/2023 4 Mantas Jesus B (Director) has filed a Form 4 on BIOGEN INC.
Txns: Granted 960 shares @ $0
06/28/2023 4 LANGER SUSAN (Director) has filed a Form 4 on BIOGEN INC.
Txns: Granted 960 shares @ $0
06/28/2023 3 LANGER SUSAN (Director) has filed a Form 3 on BIOGEN INC.
06/28/2023 4 HAWKINS WILLIAM A (Director) has filed a Form 4 on BIOGEN INC.
Txns: Granted 960 shares @ $0
06/28/2023 4 Freire Maria C (Director) has filed a Form 4 on BIOGEN INC.
Txns: Granted 960 shares @ $0
06/28/2023 4 DORSA CAROLINE (Director) has filed a Form 4 on BIOGEN INC.
Txns: Granted 1,580 shares @ $0
06/13/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
06/13/2023 DEFR14A Form DEFR14A - Revised definitive proxy soliciting materials:
06/12/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/03/2023 8-K Quarterly results
05/02/2023 4 Keeney Adam (Head of Corporate Development) has filed a Form 4 on BIOGEN INC.
Txns: Granted 2,815 restricted stock units @ $0
05/02/2023 4 Gregory Ginger (EVP, Human Resources) has filed a Form 4 on BIOGEN INC.
Txns: Sold 2,681 shares @ $300, valued at $804.3k
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy